What Makes Eravacycline a Unique Antibiotic?

Video
Conference|ID Week

Patrick Horn, MD, PhD, explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.

Patrick Horn, MD, PhD, chief medical officer at Tetraphase Pharmaceuticals explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.

Related Videos
Related Content
Pneumonia Diagnostic Shows Limited Utility

Pneumonia Diagnostic Shows Limited Utility

April 18th 2024
Article
How Do We Transition Patients on Heavy Antibiotics to Outpatient?

How Do We Transition Patients on Heavy Antibiotics to Outpatient?

December 20th 2022
Podcast
Antibiotics for Most Lower Tract Respiratory Infections Are Not Efficacious

Antibiotics for Most Lower Tract Respiratory Infections Are Not Efficacious

April 17th 2024
Article
COVID-19 Pandemic Drove Carbapenem Resistance in Gram-Negative Infections

COVID-19 Pandemic Drove Carbapenem Resistance in Gram-Negative Infections

December 14th 2022
Podcast
Evidence Supports De-Escalation of Broad-Spectrum Antibiotics in Severe Infection

Evidence Supports De-Escalation of Broad-Spectrum Antibiotics in Severe Infection

April 10th 2024
Article
Oral UTI Vaccine Demonstrates Long-Term Efficacy in Over Half of Recipients

Oral UTI Vaccine Demonstrates Long-Term Efficacy in Over Half of Recipients

April 7th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.